1. Home
  2. PRTC vs SOR Comparison

PRTC vs SOR Comparison

Compare PRTC & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • SOR
  • Stock Information
  • Founded
  • PRTC 2015
  • SOR 1968
  • Country
  • PRTC United States
  • SOR United States
  • Employees
  • PRTC N/A
  • SOR N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • SOR Investment Managers
  • Sector
  • PRTC Health Care
  • SOR Finance
  • Exchange
  • PRTC Nasdaq
  • SOR Nasdaq
  • Market Cap
  • PRTC 431.1M
  • SOR 348.7M
  • IPO Year
  • PRTC N/A
  • SOR N/A
  • Fundamental
  • Price
  • PRTC $19.10
  • SOR $41.63
  • Analyst Decision
  • PRTC Buy
  • SOR
  • Analyst Count
  • PRTC 1
  • SOR 0
  • Target Price
  • PRTC $45.00
  • SOR N/A
  • AVG Volume (30 Days)
  • PRTC 2.5K
  • SOR 16.2K
  • Earning Date
  • PRTC 04-24-2025
  • SOR 01-01-0001
  • Dividend Yield
  • PRTC N/A
  • SOR 7.24%
  • EPS Growth
  • PRTC N/A
  • SOR N/A
  • EPS
  • PRTC N/A
  • SOR 6.50
  • Revenue
  • PRTC $468,000.00
  • SOR N/A
  • Revenue This Year
  • PRTC N/A
  • SOR N/A
  • Revenue Next Year
  • PRTC $160.00
  • SOR N/A
  • P/E Ratio
  • PRTC N/A
  • SOR $6.41
  • Revenue Growth
  • PRTC N/A
  • SOR N/A
  • 52 Week Low
  • PRTC $16.30
  • SOR $36.41
  • 52 Week High
  • PRTC $34.00
  • SOR $42.75
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 58.88
  • SOR 44.80
  • Support Level
  • PRTC $16.30
  • SOR $41.27
  • Resistance Level
  • PRTC $19.78
  • SOR $42.50
  • Average True Range (ATR)
  • PRTC 0.46
  • SOR 0.78
  • MACD
  • PRTC 0.30
  • SOR 0.02
  • Stochastic Oscillator
  • PRTC 80.46
  • SOR 28.38

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About SOR Source Capital Inc.

Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.

Share on Social Networks: